+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Personalized Medicine In Oncology"

PD-1 Resistant Head and Neck Cancer Market Report 2025 - Product Thumbnail Image

PD-1 Resistant Head and Neck Cancer Market Report 2025

  • Report
  • May 2025
  • 175 Pages
  • Global
From
BCL-2 Inhibitors Market Report 2025 - Product Thumbnail Image

BCL-2 Inhibitors Market Report 2025

  • Report
  • April 2025
  • 175 Pages
  • Global
From
Targeted Therapy Market Report 2025 - Product Thumbnail Image

Targeted Therapy Market Report 2025

  • Report
  • March 2025
  • 175 Pages
  • Global
From
Chemotherapy Market Report 2025 - Product Thumbnail Image

Chemotherapy Market Report 2025

  • Report
  • February 2025
  • 200 Pages
  • Global
From
From
From
Patient Derived Xenograft (PDX) Models Market Report 2025 - Product Thumbnail Image

Patient Derived Xenograft (PDX) Models Market Report 2025

  • Report
  • April 2025
  • 200 Pages
  • Global
From
From
From
From
From
PARP Inhibitor Biomarkers - Global Strategic Business Report - Product Thumbnail Image

PARP Inhibitor Biomarkers - Global Strategic Business Report

  • Report
  • June 2025
  • 278 Pages
  • Global
From
From
Carcinoembryonic Antigen - Global Strategic Business Report - Product Thumbnail Image

Carcinoembryonic Antigen - Global Strategic Business Report

  • Report
  • June 2025
  • 485 Pages
  • Global
From
Cytotoxic Drugs - Global Strategic Business Report - Product Thumbnail Image

Cytotoxic Drugs - Global Strategic Business Report

  • Report
  • June 2025
  • 462 Pages
  • Global
From
Cancer Biological Therapy - Global Strategic Business Report - Product Thumbnail Image

Cancer Biological Therapy - Global Strategic Business Report

  • Report
  • June 2025
  • 211 Pages
  • Global
From
From
Loading Indicator

Personalized Medicine in Oncology is a field of medicine that uses genomic information to tailor treatments to individual patients. This approach is based on the idea that each patient's cancer is unique and requires a personalized approach to treatment. Genomics is used to identify the genetic mutations that are driving the cancer, and then treatments are tailored to target those mutations. This approach has the potential to improve outcomes and reduce side effects, as treatments are more targeted and tailored to the individual patient. Companies in the Personalized Medicine in Oncology market include Illumina, Thermo Fisher Scientific, QIAGEN, Agilent Technologies, and PerkinElmer. Show Less Read more